From metabolic therapy to addiction care: a clinical pharmacology roadmap for GLP-1 receptor agonists in substance use disorders
Expert review of clinical pharmacology · 2026 Oct 30 · Qeadan F, Madden EF, Burge MR et
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 29 20:00 ETSource: Expert review of clinical pharmacology
From the source
Read at pubmed.ncbi.nlm.nih.govFrom metabolic therapy to addiction care: a clinical pharmacology roadmap for GLP-1 receptor agonists in substance use disorders
Expert review of clinical pharmacology · 2026 Oct 30 · Qeadan F, Madden EF, Burge MR et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42960702/
